...
首页> 外文期刊>Harm Reduction Journal >Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use
【24h】

Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use

机译:有定期注射毒品史的被监禁男性队列中接受基于监狱的带回家纳洛酮计划

获取原文

摘要

Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity for THN initiatives. However, whether Australian prisoners would utilise such programmes is unknown. We examined the acceptability of THN in a cohort of male prisoners with histories of regular injecting drug use (IDU) in Victoria, Australia. The sample comprised 380 men from the Prison and Transition Health (PATH) Cohort Study; all of whom reported regular IDU in the 6?months prior to incarceration. We asked four questions regarding THN during the pre-release baseline interview, including whether participants would be willing to participate in prison-based THN. We describe responses to these questions along with relationships between before- and during-incarceration factors and willingness to participate in THN training prior to release from prison. Most participants (81%) reported willingness to undertake THN training prior to release. Most were willing to resuscitate a friend using THN if they were trained (94%) and to be revived by a trained peer (91%) using THN. More than 10?years since first injection (adjusted odds ratio [AOR] 2.22, 95%CI 1.03–4.77), having witnessed an opioid overdose in the last 5?years (AOR 2.53, 95%CI 1.32–4.82), having ever received alcohol or other drug treatment in prison (AOR 2.41, 95%CI 1.14–5.07) and injecting drugs during the current prison sentence (AOR 4.45, 95%CI 1.73–11.43) were significantly associated with increased odds of willingness to participate in a prison THN programme. Not specifying whether they had injected during their prison sentence (AOR 0.37, 95%CI 0.18–0.77) was associated with decreased odds of willingness to participate in a prison THN training. Our findings suggest that male prisoners in Victoria with a history of regular IDU are overwhelmingly willing to participate in THN training prior to release. Factors associated with willingness to participate in prison THN programmes offer insights to help support the implementation and uptake of THN programmes to reduce opioid-overdose deaths in the post-release period.
机译:带回家的纳洛酮(THN)计划是一项基于证据的阿片类药物过量预防倡议。监狱释放后阿片类药物过量的风险升高,这意味着从羁押释放释放为THN计划提供了理想的机会。但是,澳大利亚囚犯是否会利用此类程序尚不清楚。我们检查了澳大利亚维多利亚州一群有定期注射吸毒史(IDU)的男性囚犯中THN的可接受性。样本包括380名来自“监狱与过渡健康(PATH)队列研究”的男性;所有这些人在被监禁前的6个月内都报告了常规的注射用药。在发布前的基线采访中,我们问了关于THN的四个问题,包括参与者是否愿意参加基于监狱的THN。我们描述了对这些问题的回答,以及入狱前和入狱中因素之间的关系,以及出狱前参加THN培训的意愿。大多数参与者(81%)报告说愿意在发布前接受THN培训。大多数人愿意接受THN的训练(94%),并愿意接受THN训练的同伴(91%)使他们恢复生命。自首次注射以来已超过10年(调整后的优势比[AOR] 2.22,95%CI 1.03–4.77),最近5年内出现了阿片类药物过量(AOR 2.53,95%CI 1.32–4.82),在监狱中接受过酒精或其他药物治疗(AOR 2.41,95%CI 1.14–5.07)以及在当前监狱服刑期间注射毒品(AOR 4.45,95%CI 1.73-11.43)与参加某项活动的意愿几率显着相关监狱THN计划。没有说明他们是否在服刑期间注射过疫苗(AOR 0.37,95%CI 0.18–0.77)与参加监狱THN培训的意愿降低有关。我们的研究结果表明,维多利亚州有定期注射毒品使用者历史的男性囚犯在释放前绝大多数都愿意参加THN培训。与愿意参与监狱THN计划相关的因素提供了见解,以帮助支持THN计划的实施和采用,以减少释放后阿片类药物过量的死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号